TrialInvestigational new drugs2008
Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation.
J Tol et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled ittrialcites it